Physician profile
Alan J Barcomb
NPI 1548220775
$1,268.05
in general payments reported to CMS, 2019-2025
18 companies · $47.23 in 2025
The $47.23 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,024 · 2020: $65.04 · 2022: $118 · 2024: $13.81 · 2025: $47.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $61.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $61.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $358.46 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $158.50 | 2019-2020 | |
| Indivior INC. | $152.62 | 2019-2022 | |
| Glaxosmithkline, LLC. | $124.04 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.37 | 2019 | |
| Pfizer INC. | $59.06 | 2019 | |
| Janssen Pharmaceuticals, INC | $57.88 | 2019 | |
| Bausch Health US, LLC | $36.91 | 2019 | |
| Lilly USA, LLC | $35.83 | 2019 | |
| Merck Sharp & Dohme LLC | $26.26 | 2019 | |
| Exact Sciences Corporation | $26.05 | 2025 | Cologuard Collection Kit |
| Teva Pharmaceuticals USA, INC. | $21.23 | 2019 | |
| Electromed, INC. | $21.18 | 2025 | Smartvest |
| Upsher-Smith Laboratories LLC | $17.93 | 2019 | |
| Shire North American Group INC | $13.90 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $13.81 | 2024 | Vivitrol |
| Sanofi-Aventis U.S. LLC | $13.77 | 2019 | |
| Abbvie INC. | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Barcomb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.